4.3 Review

Drosophila insulin-like peptides: from expression to functions - a review

Journal

ENTOMOLOGIA EXPERIMENTALIS ET APPLICATA
Volume 169, Issue 2, Pages 195-208

Publisher

WILEY
DOI: 10.1111/eea.12981

Keywords

insulin‐ like peptides; insulin receptor; aging; metabolism; Drosophila; Diptera; Drosophilidae; fruit flies; hormones; genetic manipulation; DILPs; human health span

Categories

Funding

  1. Ministry of Education and Science of Ukraine [0117U006426]
  2. Natural Sciences and Engineering Research Council of Canada [6793]

Ask authors/readers for more resources

Insulin-like peptides (ILPs) are important in fruit flies, activating intracellular proteins to participate in various functions such as physiological regulation and growth. Recent research focuses on the structure of ILPs, as well as how environmental factors and genetic manipulations affect their function, and their association with lifespan and metabolism in fruit flies.
Insulin-like peptides (ILPs) belong to the insulin superfamily and act as hormones, neuromediators, and growth factors during the post-embryonic life-cycle stages of insects. These peptides are encoded by different genes in various species. In the genus Drosophila, eight peptides are known, seven of which are likely to bind the Drosophila insulin receptor, whereas DILP8 is a known ligand of the Lgr3 receptor. Binding of DILPs 1-7 to receptors leads to activation of intracellular proteins related to the conserved insulin/IGF (insulin-like growth factors) signaling pathway. The insulin pathway acts within a complex physiological regulatory network involved in the coordination of development, growth, behavior, metabolism, lifespan, and cognitive functions in insects. The current review summarizes recent data about the structure and function of ILPs in fruit flies. The role of environmental factors and genetic manipulations in modulating the functions of DILPs and their association with lifespan and metabolism of Drosophila are assessed. Further investigation and identification of pharmacological or biotechnological interventions that may decrease insulin/IGF signaling could be a highly promising approach for extension of human health span and longevity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available